Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Li... ( Up to One Quarter of Managed Care Or...)

HOME >> BIOLOGY >> TECHNOLOGY

Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting

Date:10/16/2007

Up to One Quarter of Managed Care Organizations Fail to Cover Agents with Proven Benefit for Cancer Patients, According to a New Report from Decision

Resources

WALTHAM, Mass., Oct. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that oncologists want to see significant improvement in overall survival before adopting targeted polypharmacy in first-line settings. According to the new Physician & Payer Forum report entitled Premium-Priced Targeted Agents in Oncology: Clinician and Payer Attitudes to Polypharmacy, surveyed oncologists were asked what the minimum benefit is that would persuade them to add ImClone/Bristol-Myers Squibb/Merck KGaA's Erbitux to Genentech/Roche's Avastin and chemotherapy for first-line treatment of advanced non-small-cell lung cancer (NSCLC).

In this first-line treatment scenario, the largest group of oncologists (41 percent) would require a significant improvement in overall survival in order to add Erbitux to Avastin and chemotherapy. On average, oncologists require 24 percent improvement in median survival, which would represent close to three months' additional survival, a very difficult requirement to meet in advanced NSCLC. Only 37 percent of oncologists expect Erbitux/Avastin to increase median survival of NSCLC patients.

The report also finds that up to one quarter of managed care organizations (MCOs) fail to cover both agents where two similar targeted agents are available. Marketers of Tykerb, Nexavar, Sutent, and Sprycel need to address the fact that some MCOs appear to perceive Herceptin/Tykerb, Nexavar/Sutent, and Gleevec/Sprycel as interchangeable, "me too" agents.

"Evidence demonstrates that patients who have failed Herceptin in the metastatic setting should switch to Tykerb, patients who have failed Gleevec should switch to Sprycel, and, according to National Cancer Instit
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Emerging technology companies receive significant funding
2. Genzyme acquistion of Bone Care approved, significant impact forecast
3. Chicago-Milwaukee "mega-metro" infrastructure improvements are critical
4. Manufacturing group says efforts led to big improvements
5. Part 6 Project Performance Get on the path to continuous improvement
6. Part 5 Project Performance Get on the path to continuous improvement
7. Part 4 Project Performance Get on the path to continuous improvement
8. Part 3 Project performance Get on the path to continuous improvement
9. Part 2 Project performance Get on the path to continuous improvement
10. Part 1 Project performance Get on the path to continuous improvement
11. Finding a Yardstick For Local Biotech Improvement and Success

Post Your Comments:

(Date:5/21/2013)... Austin, TX (PRWEB) May 21, 2013 ... and outdoor security solutions, today announced that Genzyme, a ... more units of Door Detective® CL for a multi-use ... already installed in four other Genzyme buildings, this latest ... had with the tailgate detection device improving ...

(Date:5/21/2013)... Many have long discussed the link between mental ... from Clinical Psychiatry.com readdressed the topic of ... suggested using hypnotherapy and other mental health ... that cause acne. , Doctors in the article mentioned ... stress causes changes in the skin that have been ...

(Date:5/21/2013)... May 21, 2013 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, ... the Grand Hyatt Hotel. Mr. Riley is scheduled to present ... of Synthetic Biologics, presentation can be accessed by logging onto ...

(Date:5/21/2013)... May 21, 2013 Revolutionary Science, the ... colony counter, announced today that they have expanded their ... , the IncuCount, IntelliCount, InCount and ImpressCount. These ... are especially useful in food microbiology and pharmaceutical manufacturing. ... updated look. A bright white enclosure with jet ...

Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3 Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2 Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2 Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2

[0] Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security [0] Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions [0] Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference [0] Revolutionary Science Announces New Automatic and Manual Colony Counting Products

... Productivity. , ... Grand Forks, ND (Vocus) December 10, ... individual management practices and fields will become increasingly important to growers, ... Research and Development, will tell agricultural leaders today at the ...

... Dosing Regimen , , ... long-acting therapy (LAT) demonstrated statistically significant symptom control compared ... study presented today (1). Statistical significance was evidenced ... equivalent [eq.a]), when given every 4 weeks with a ...

... Journal Blood for the American Society of Hematology Annual Meeting ... 10 Alfacell Corporation (Nasdaq: ACEL ) today ... in Blood (2008 112: Abstract 4205 & 2008 ... show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ...

Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells

(Date:5/20/2013)... articles posted online ahead of print 9 ... of geoscience subdisciplines, including minerals exploration, archaeology, planetary ... include Siberia; the Sumatran subduction margin; the Monte ... and the Southeastern U.S. Atlantic Margin. Brief highlights ... tectonics;, 2. The clear fingerprint of ice ages ...

(Date:5/19/2013)... engineered a strain of photosynthetic cyanobacteria to grow without ... today at the 113th General Meeting of the American ... synthetic biology approaches to probe and rewire photoautotrophic (exclusively ... cyanobacterial metabolism for the ability to grow without light ... study. He is part of Shota Atsumi,s lab ...

(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...

[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] Engineered microbes grow in the dark [0] Research examines new methods for managing digestive health

... species previously unknown to science have been discovered on ... environment surrounding hydrothermal vents. The discoveries, made by ... Southampton and British Antarctic Survey, include new species of ... octopus. For the first time, researchers have used ...

... 2011 By manipulating the way bacteria "talk" to ... an unprecedented degree of control over the formation and ... health and industrial applications, particularly to bioreactor technology. ... K. Wood and Associate Professor Arul Jayaraman of the ...

... disguised herself as a man to work as ... French circumnavigation of the globe. The expedition consisted of ... Bougainville and was expected to take three years. A ... vessels; prejudice and custom prevented their participation in science. ...

Cached Biology News:'Lost world' discovered around Antarctic vents 2 Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say 2 Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say 3 Jeanne Baret, botanist and first female circumnavigator, finally commemorated in name of new species 2

'Lost world' discovered around Antarctic vents Manipulating way bacteria 'talk' could have practical applications, Texas A&M profs say Jeanne Baret, botanist and first female circumnavigator, finally commemorated in name of new species

...

Applications include ELISA, immunochemistry, and Western blotting. Working Concentrations: ELISA: 0.005-0.05 U/ml, immunohisto/cytochemistry: 0.25-0.5 U/ml, Western blot: 0.1-0.25 U/ml....

Poly A Polymerase catalyzes the addition of AMP to the 3' hydroxyl terminus of RNA. Poly A Polymerase can add poly(C) and poly(U) to RNA but does so with much-reduced efficiency....

Biology Products:

Mae II from Roche Applied Science Xho I from Roche Applied Science Streptavidin, Unconjugated from Roche Applied Science Poly A Polymerase from Invitrogen